Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:56 am Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 446,780 7.330% | 91,848 (+25.88%) | Filing History |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 582,392 9.600% | 96,378 (+19.83%) | Filing History |
| 2024-01-17 4:54 pm Purchase | 2024-01-10 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (US) LLC | 345,183 5.700% | 345,183 (New Position) | Filing History |
| 2023-10-10 4:52 pm Purchase | 2023-09-28 | 13G | Sutro Biopharma, Inc. STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 354,932 5.860% | 354,932 (New Position) | Filing History |
| 2023-02-14 3:00 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 0 0.000% | -270,898 (Position Closed) | Filing History |
| 2023-02-14 11:45 am Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 334,795 5.800% | 18,753 (+5.93%) | Filing History |
| 2023-02-13 10:56 am Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 556,510 9.700% | 309,130 (+124.96%) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 321,187 5.590% | 321,187 (New Position) | Filing History |
| 2023-02-07 2:55 pm Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 486,014 8.500% | 116,010 (+31.35%) | Filing History |
| 2023-02-01 1:09 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 283,814 4.900% | -42,981 (-13.15%) | Filing History |
| 2023-01-23 4:31 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Millennium Management LLC | 136,902 2.400% | -105,365 (-43.49%) | Filing History |
| 2022-07-08 4:19 pm Purchase | 2022-07-01 | 13G | Sutro Biopharma, Inc. STRO | Millennium Management LLC | 242,267 5.200% | 242,267 (New Position) | Filing History |
| 2022-02-14 12:00 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | Eventide Asset Management, LLC | 270,898 5.900% | 33,800 (+14.26%) | Filing History |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 247,380 5.400% | 6,540 (+2.72%) | Filing History |
| 2022-02-04 1:45 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | FRANKLIN RESOURCES INC BEN | 326,795 7.100% | 326,795 (New Position) | Filing History |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | BlackRock Inc. BLK | 370,004 8.000% | 98,211 (+36.13%) | Filing History |
| 2022-01-18 5:18 pm Purchase | 2022-01-07 | 13G | Sutro Biopharma, Inc. STRO | BIOTECHNOLOGY VALUE FUND L P | 316,042 6.800% | 130,625 (+70.45%) | Filing History |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 240,840 5.200% | 240,840 (New Position) | Filing History |
| 2021-04-05 5:28 pm Purchase | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | BRISTOL MYERS SQUIBB CO BMY | 172,620 3.800% | 172,620 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Citadel Advisors LLC | 130,180 2.900% | -42,717 (-24.71%) | Filing History |